{
    "abstract": "There are high rates of comorbidity between posttraumatic stress disorder (PTSD) and opioid use disorder (OUD). Evidence-based trauma-focused psychotherapies such as Cognitive Processing Therapy (CPT) are a first-line treatment for PTSD. Veterans with OUD are treated primarily in substance use disorder (SUD) clinics where the standard of care is drug counseling; they often do not have access to first-line PTSD treatments. This study tested whether CPT can be conducted safely and effectively in veterans with comorbid OUD treated with buprenorphine.\nThis 12-week, 2-site, randomized clinical trial (RCT) included open-label randomization to two groups: (a) CPT versus (b) Individual Drug Counselling (IDC) in veterans with PTSD and comorbid OUD who were maintained on buprenorphine (N\u2009=\u200938).\nVeterans randomized to either IDC (n\u2009=\u200918) or CPT (n\u2009=\u200920) showed a significant reduction in self-reported PTSD symptoms over time as measured by the PTSD checklist (PCL-5) but there were no treatment group differences; there was some indication that reduction in PTSD symptoms in the CPT group were sustained in contrast to the IDC group. Recruitment was significantly impacted by COVID-19 pandemic, so this study serves as a proof-of-concept pilot study.\nVeterans with OUD and PTSD can safely and effectively participate in evidence-based therapy for PTSD; further work should confirm that trauma-focused treatment may be more effective in leading to sustained remission of PTSD symptoms than drug counseling.\nThis is the first study to evaluate CPT for PTSD in the context of buprenorphine treatment for OUD.",
    "authors": [
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.\nDepartment of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA.",
            "firstname": "Ismene L",
            "initials": "IL",
            "lastname": "Petrakis"
        },
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.\nDepartment of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA.",
            "firstname": "Sarah",
            "initials": "S",
            "lastname": "Meshberg-Cohen"
        },
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.",
            "firstname": "Charla",
            "initials": "C",
            "lastname": "Nich"
        },
        {
            "affiliation": "Department of Psychiatry, VA Bedford Healthcare System, Bedford, Massachusetts, USA.\nDepartment of Psychiatry, UMass Chan Medical School, North Worcester, Massachusetts, USA.",
            "firstname": "Megan M",
            "initials": "MM",
            "lastname": "Kelly"
        },
        {
            "affiliation": "Department of Psychiatry, VA Bedford Healthcare System, Bedford, Massachusetts, USA.",
            "firstname": "Tracy",
            "initials": "T",
            "lastname": "Claudio"
        },
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.\nDepartment of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA.",
            "firstname": "Jane Serrita",
            "initials": "JS",
            "lastname": "Jane"
        },
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.\nDepartment of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA.",
            "firstname": "Emily",
            "initials": "E",
            "lastname": "Pisani"
        },
        {
            "affiliation": "Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.\nDepartment of Psychiatry, VA Connecticut Healthcare System, West Haven, Connecticut, USA.",
            "firstname": "Elizabeth",
            "initials": "E",
            "lastname": "Ralevski"
        }
    ],
    "conclusions": null,
    "copyrights": "\u00a9 2024 The American Academy of Addiction Psychiatry (AAAP).",
    "doi": "10.1111/ajad.13557",
    "journal": "The American journal on addictions",
    "keywords": [],
    "methods": null,
    "publication_date": "2024-04-16",
    "pubmed_id": "38624259",
    "results": "Veterans randomized to either IDC (n\u2009=\u200918) or CPT (n\u2009=\u200920) showed a significant reduction in self-reported PTSD symptoms over time as measured by the PTSD checklist (PCL-5) but there were no treatment group differences; there was some indication that reduction in PTSD symptoms in the CPT group were sustained in contrast to the IDC group. Recruitment was significantly impacted by COVID-19 pandemic, so this study serves as a proof-of-concept pilot study.",
    "title": "Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine.",
    "xml": "<Element 'PubmedArticle' at 0x788502e61530>"
}